Last reviewed · How we verify

[14C]D-0316 suspension

Betta Pharmaceuticals Co., Ltd. · Phase 1 active Small molecule

[14C]D-0316 suspension is a Small molecule drug developed by Betta Pharmaceuticals Co., Ltd.. It is currently in Phase 1 development.

At a glance

Generic name[14C]D-0316 suspension
SponsorBetta Pharmaceuticals Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about [14C]D-0316 suspension

What is [14C]D-0316 suspension?

[14C]D-0316 suspension is a Small molecule drug developed by Betta Pharmaceuticals Co., Ltd..

Who makes [14C]D-0316 suspension?

[14C]D-0316 suspension is developed by Betta Pharmaceuticals Co., Ltd. (see full Betta Pharmaceuticals Co., Ltd. pipeline at /company/betta-pharmaceuticals-co-ltd).

What development phase is [14C]D-0316 suspension in?

[14C]D-0316 suspension is in Phase 1.

Related